Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
KURA
#2385
Kura Oncology, Inc. - Common Stock
12.6
6
USD
-0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-3.95%
Monthly Change
+41.61%
6 month change
+48.94%
Year Change
+58.45%
Previous Close
13.1
8
Open
12.6
6
Low
12.6
6
High
12.6
6
Volume
121
Markets
US Stock Market
Healthcare
Biotechnology
KURA
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
66.21 M
66.61 M
68.44 M
76.14 M
80.75 M
88.33 M
88.96 M
Valuation ratios
Enterprise value
1.84 B
846.18 M
782.04 M
1.14 B
488.44 M
778.36 M
1.12 B
Price to earnings ratio
—
—
-5.94
-7.38
-4.31
-3.27
-3.95
Price to sales ratio
—
—
—
—
13.93
13.5
15.22
Price to cash flow ratio
—
—
7.33
9.01
5.59
-14.22
-10.62
Price to book ratio
—
—
1.92
2.83
1.81
5.23
2.04
Enterprise value to EBITDA ratio
—
-6.25
—
—
-2.38
-2.51
-3.5
Profitability ratios
Return on assets %
-0.14
-0.24
-0.3
-0.34
-0.23
-0.38
-0.12
Return on equity %
-0.15
-0.26
-0.32
-0.38
-0.42
-1.6
-1.41
Return on invested capital %
-4 731.27
-4 261.24
-4 669.95
-4 398.28
-2 461.64
-1 051.26
-248.38
Gross margin %
—
100
—
—
100
100
98.84
Operating margin %
—
62.01 K
—
—
-358.55
-449.94
-349.77
EBITDA margin %
—
63.82 K
—
—
-380.39
-460.23
-351.02
Net margin %
—
61.54 K
—
—
-322.89
-412.95
-327.33
Liquidity ratios
Quick ratio
—
—
—
—
—
6.05
4.71
Current ratio
24.49
23.26
18.56
12.26
9.46
6.06
4.73
Inventory turnover
—
—
—
—
—
—
0.15
Asset turnover
—
-0
—
—
0.09
0.09
0.03
Solvency ratios
Debt to assets ratio
0.01
0.01
0.02
0.02
0.01
0.01
0.02
Debt to equity ratio
0.01
0.01
0.02
0.02
0.02
0.06
0.2
Long term debt to total assets ratio
0.01
—
0.02
0.02
0.01
0.01
—
Long term debt to total equity ratio
0.01
—
0.02
0.03
0.02
0.06
—
Per share metrics
Operating cash flow per share
—
—
-1.64
-1.7
1.56
-0.73
-1.26
EBIT per share
—
—
—
—
-2.24
-3.46
-3.61
EBITDA per share
—
—
—
—
-2.38
-3.54
-3.64
Total debt per share
—
—
0.14
0.13
0.11
0.11
0.11
Cash per share
—
—
6.54
5.79
8.44
7.61
5.84
Net current asset value per share
—
—
6.66
5.91
8.64
8.08
6.3
Tangible book value per share
—
—
6.27
5.43
4.8
1.99
0.55
Working capital per share
—
—
6.3
5.42
7.73
6.75
4.97
Book value per share
—
—
6.27
5.43
4.8
1.99
0.55
News
Oncology Stocks to Add to Your Portfolio as Cancer Care Evolves
Kura Oncology: 'Strong Buy' Ziftomenib AML Expansions Could Boost KOMZIFTI's Prospects
Company News for Aug 26, 2026
The $1.24 Billion Reason Why Kura Oncology Stock Is Up Today
Kura Oncology (KURA) is a Great Momentum Stock: Should You Buy?
Does Kura Oncology (KURA) Have the Potential to Rally 178.55% as Wall Street Analysts Expect?
Kura Oncology, Inc. (KURA) Q2 2026 Earnings Call Transcript
Kura Oncology (KURA) Reports Q2 Loss, Beats Revenue Estimates
C4 Therapeutics, Inc. (CCCC) Reports Q2 Loss, Tops Revenue Estimates
TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates
Agenus (AGEN) Reports Q2 Loss, Tops Revenue Estimates
Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates